aluates Reports

$ 0.0

Automative

Global Amyotrophic Lateral Sclerosis Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34U13892

Global Amyotrophic Lateral Sclerosis Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Amyotrophic Lateral Sclerosis Therapeutics Market Insights, Forecast to 2030

Code: QYRE-Auto-34U13892

Report

December 2024

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Sanofi

Mylan Pharma

Apotex

Glemark Generics

Covis Pharma

Sun Pharma

Lunan Pharma

Amyotrophic Lateral Sclerosis Therapeutics Market Size

The global Amyotrophic Lateral Sclerosis Therapeutics market is projected to grow from US$ 325 million in 2024 to US$ 396.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.

Amyotrophic Lateral Sclerosis Therapeutics Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.

The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.

Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Therapeutics Market

The amyotrophic lateral sclerosis (ALS) therapeutics market is driven by the increasing prevalence of ALS and the growing demand for effective treatments to slow disease progression and improve patient outcomes. As the understanding of ALS pathophysiology improves, researchers and pharmaceutical companies are actively exploring novel therapeutic approaches, including gene therapies and immune-modulating agents. The approval of new ALS drugs and the development of combination therapies further propel market growth. However, challenges include the complexity of ALS as a multi-factorial disease, the difficulty in diagnosing ALS at an early stage, and the high cost of drug development and clinical trials. Addressing these challenges through collaborative research, improved diagnostic tools, and accessible treatment options will be crucial for the sustained growth of the ALS therapeutics market.

Report Covers:

This report presents an overview of global market for Amyotrophic Lateral Sclerosis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Amyotrophic Lateral Sclerosis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amyotrophic Lateral Sclerosis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amyotrophic Lateral Sclerosis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Amyotrophic Lateral Sclerosis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Amyotrophic Lateral Sclerosis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Amyotrophic Lateral Sclerosis Therapeutics Market Report

Report Metric	Details
Report Name	Amyotrophic Lateral Sclerosis Therapeutics Market
Accounted market size in 2024	US$ 325 million
Forecasted market size in 2030	US$ 396.8 million
CAGR	3.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Riluzole Edaravone (Radicava) Other
Segment by Application	Hospital Drugs Store Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Amyotrophic Lateral Sclerosis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amyotrophic Lateral Sclerosis Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Therapeutics Market growing?

Ans: The Amyotrophic Lateral Sclerosis Therapeutics Market witnessing a CAGR of 3.4 during the forecast period 2025-2030.

What is the Amyotrophic Lateral Sclerosis Therapeutics Market size in 2030?

Ans: The Amyotrophic Lateral Sclerosis Therapeutics Market size in 2030 will be US$ 396.8 million.

Who are the main players in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis Therapeutics Market are Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis Therapeutics Market report are Riluzole, Edaravone (Radicava), Other

Recommended Reports

Neurodegenerative Disorders

Muscular Dystrophy Drugs

Rare Genetic Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Riluzole

1.2.3 Edaravone (Radicava)

1.2.4 Other

1.3 Market by Application

1.3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Drugs Store

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Perspective (2019-2030)

2.2 Global Amyotrophic Lateral Sclerosis Therapeutics Growth Trends by Region

2.2.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Dynamics

2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Industry Trends

2.3.2 Amyotrophic Lateral Sclerosis Therapeutics Market Drivers

2.3.3 Amyotrophic Lateral Sclerosis Therapeutics Market Challenges

2.3.4 Amyotrophic Lateral Sclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Amyotrophic Lateral Sclerosis Therapeutics by Players

3.1.1 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio

3.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2023

3.5 Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics Head office and Area Served

3.6 Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Product and Application

3.7 Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Type

4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2025-2030)

5 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Application

5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

6.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type

6.2.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

6.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application

6.3.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

6.4 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country

6.4.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type

7.2.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application

7.3.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

7.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country

7.4.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

8.2 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type

8.2.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)

8.2.2 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030)

8.2.3 China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

8.3 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application

8.3.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)

8.3.2 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030)

8.3.3 China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

9.2 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type

9.2.1 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

9.3 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application

9.3.1 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

9.4 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region

9.4.1 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Mitsubishi Tanabe Pharma

11.1.1 Mitsubishi Tanabe Pharma Company Details

11.1.2 Mitsubishi Tanabe Pharma Business Overview

11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.1.5 Mitsubishi Tanabe Pharma Recent Developments

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.2.5 Sanofi Recent Developments

11.3 Mylan Pharma

11.3.1 Mylan Pharma Company Details

11.3.2 Mylan Pharma Business Overview

11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.3.5 Mylan Pharma Recent Developments

11.4 Apotex

11.4.1 Apotex Company Details

11.4.2 Apotex Business Overview

11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.4.5 Apotex Recent Developments

11.5 Glemark Generics

11.5.1 Glemark Generics Company Details

11.5.2 Glemark Generics Business Overview

11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.5.5 Glemark Generics Recent Developments

11.6 Covis Pharma

11.6.1 Covis Pharma Company Details

11.6.2 Covis Pharma Business Overview

11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.6.5 Covis Pharma Recent Developments

11.7 Sun Pharma

11.7.1 Sun Pharma Company Details

11.7.2 Sun Pharma Business Overview

11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.7.5 Sun Pharma Recent Developments

11.8 Lunan Pharma

11.8.1 Lunan Pharma Company Details

11.8.2 Lunan Pharma Business Overview

11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction

11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

11.8.5 Lunan Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Mitsubishi Tanabe Pharma

Sanofi

Mylan Pharma

Apotex

Glemark Generics

Covis Pharma

Sun Pharma

Lunan Pharma

List of Tables

Table 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Riluzole

Table 3. Key Players of Edaravone (Radicava)

Table 4. Key Players of Other

Table 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2024)

Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2025-2030)

Table 11. Amyotrophic Lateral Sclerosis Therapeutics Market Trends

Table 12. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers

Table 13. Amyotrophic Lateral Sclerosis Therapeutics Market Challenges

Table 14. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints

Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Players (2019-2024)

Table 17. Global Top Amyotrophic Lateral Sclerosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)

Table 18. Global Amyotrophic Lateral Sclerosis Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Product and Application

Table 22. Global Key Players of Amyotrophic Lateral Sclerosis Therapeutics, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Application (2019-2024)

Table 30. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Application (2025-2030)

Table 32. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Amyotrophic Lateral Sclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Amyotrophic Lateral Sclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Amyotrophic Lateral Sclerosis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 64. Mitsubishi Tanabe Pharma Company Details

Table 65. Mitsubishi Tanabe Pharma Business Overview

Table 66. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 67. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 68. Mitsubishi Tanabe Pharma Recent Developments

Table 69. Sanofi Company Details

Table 70. Sanofi Business Overview

Table 71. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product

Table 72. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 73. Sanofi Recent Developments

Table 74. Mylan Pharma Company Details

Table 75. Mylan Pharma Business Overview

Table 76. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 77. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 78. Mylan Pharma Recent Developments

Table 79. Apotex Company Details

Table 80. Apotex Business Overview

Table 81. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product

Table 82. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 83. Apotex Recent Developments

Table 84. Glemark Generics Company Details

Table 85. Glemark Generics Business Overview

Table 86. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product

Table 87. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 88. Glemark Generics Recent Developments

Table 89. Covis Pharma Company Details

Table 90. Covis Pharma Business Overview

Table 91. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 92. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 93. Covis Pharma Recent Developments

Table 94. Sun Pharma Company Details

Table 95. Sun Pharma Business Overview

Table 96. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 97. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 98. Sun Pharma Recent Developments

Table 99. Lunan Pharma Company Details

Table 100. Lunan Pharma Business Overview

Table 101. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product

Table 102. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)

Table 103. Lunan Pharma Recent Developments

Table 104. Research Programs/Design for This Report

Table 105. Key Data Information from Secondary Sources

Table 106. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Riluzole Features

Figure 4. Edaravone (Radicava) Features

Figure 5. Other Features

Figure 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Drugs Store Case Studies

Figure 10. Other Case Studies

Figure 11. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered

Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2023

Figure 16. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2023

Figure 18. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

Figure 20. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

Figure 21. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 22. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

Figure 26. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

Figure 27. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 28. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

Figure 36. China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

Figure 37. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

Figure 39. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

Figure 40. Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2030)

Figure 41. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)

Figure 51. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 58. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 59. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 60. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 61. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 62. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 63. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 64. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Amyotrophic Lateral Sclerosis ALS Market Insights Forecast to 2030

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Amyotrophic Lateral Sclerosis ALS Devices Market Research Report 2024

Global Neurodegenerative Disease Market Insights Forecast to 2030

Global Amyotrophic Lateral Sclerosis Device Market Research Report 2025

Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Alzheimer Treatment Drug Market Research Report 2025

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Rilutek Market Insights Forecast to 2030

Global Neurodegenerative Disease Treatment Market Research Report 2024

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TIGLUTIK Market Insights Forecast to 2030

Global Teglutik Market Insights Forecast to 2030

Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions